Gilotrif is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test Gilotrif (afatinib) should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

What is Gilotrif used for?

Gilotrif is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC), 1. that has certain types of abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer that has spread to other parts of the body

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Gilotrif (afatinib) on prescription and Import License in Patient's Name only.

For Gilotrif or afatinib price in India.
Contact at +91 9811747774 or Email Us
Gilotrif (afatinib)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals Gilotrif (afatinib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.